Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAPROXEN\SUMATRIPTAN vs NATEGLINIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAPROXEN\SUMATRIPTAN vs NATEGLINIDE: Safety Overview

Metric NAPROXEN\SUMATRIPTAN NATEGLINIDE
Total FAERS Reports 233 183
Deaths Reported 15 19
Death Rate 6.4% 10.4%
Hospitalizations 14 51
Average Patient Age 47.8 yrs 64.0 yrs
% Female Patients 84.5% 60.3%
FDA Approval Date N/A Apr 19, 2019
Manufacturer N/A Zydus Lifesciences Limited
Route N/A ORAL
Marketing Status N/A Discontinued